Globus Medical GMED · NYSE
$76.67 -2.76% (-$2.18)
Summary
80 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 28% a year over the last 3 years.
- Out of every 100 USD of revenue, 17 USD is left as net profit.
- It holds more cash than debt: $507.7M against $111.2M.
- The share price is below the Bulios Fair Price.
What to watch
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 19.8 USD for 1 USD of yearly profit. Over the last five years it was 54.6 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 30% a year over 5 years. Over the last 3 years it grew by 42% a year. For the next fiscal year analysts expect revenue to grow by 8.9%. Earnings per share grew by 28% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 31 USD
- Research and development 5.9 USD
- Sales and administration 42 USD
- Taxes and other 3.7 USD
- Net profit 17 USD
Net profit, industry median (Medical - Devices) 7.0 USD
Out of every 100 USD of revenue, 17 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 26
- Hold 9
- Sell 1
Today's price within the analysts' price targets
The average target of $95.13 is 24% above today's price. 72% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2024By product
- Spine 94%
- Emerging Technology 6.1%
By region
- UNITED STATES 100%
Spine brings in 94% of revenue. Emerging Technology grew fastest, by 40% a year.
Segments in detail